Bank of New York Mellon’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19K Sell
57,697
-108,066
-65% -$35.7K ﹤0.01% 4094
2025
Q1
$51.7K Hold
165,763
﹤0.01% 4032
2024
Q4
$155K Hold
165,763
﹤0.01% 3969
2024
Q3
$196K Sell
165,763
-52,400
-24% -$61.8K ﹤0.01% 3903
2024
Q2
$168K Sell
218,163
-11,390
-5% -$8.76K ﹤0.01% 3970
2024
Q1
$700K Sell
229,553
-19,256
-8% -$58.7K ﹤0.01% 3328
2023
Q4
$801K Sell
248,809
-1,271
-0.5% -$4.09K ﹤0.01% 3305
2023
Q3
$960K Buy
250,080
+442
+0.2% +$1.7K ﹤0.01% 3178
2023
Q2
$819K Buy
249,638
+166,624
+201% +$547K ﹤0.01% 3318
2023
Q1
$214K Hold
83,014
﹤0.01% 3887
2022
Q4
$154K Sell
83,014
-140,474
-63% -$261K ﹤0.01% 4043
2022
Q3
$411K Buy
223,488
+4,601
+2% +$8.46K ﹤0.01% 3678
2022
Q2
$470K Sell
218,887
-12,121
-5% -$26K ﹤0.01% 3640
2022
Q1
$726K Sell
231,008
-21,165
-8% -$66.5K ﹤0.01% 3498
2021
Q4
$810K Buy
252,173
+134,673
+115% +$433K ﹤0.01% 3505
2021
Q3
$396K Buy
117,500
+25,653
+28% +$86.5K ﹤0.01% 3924
2021
Q2
$359K Sell
91,847
-59,183
-39% -$231K ﹤0.01% 3909
2021
Q1
$607K Buy
151,030
+15,767
+12% +$63.4K ﹤0.01% 3576
2020
Q4
$313K Buy
135,263
+13,708
+11% +$31.7K ﹤0.01% 3808
2020
Q3
$698K Sell
121,555
-1,018
-0.8% -$5.85K ﹤0.01% 3322
2020
Q2
$903K Buy
122,573
+101,110
+471% +$745K ﹤0.01% 3164
2020
Q1
$64K Buy
+21,463
New +$64K ﹤0.01% 3927
2019
Q2
Sell
-34,650
Closed -$61K 4254
2019
Q1
$61K Sell
34,650
-116
-0.3% -$204 ﹤0.01% 4066
2018
Q4
$84K Buy
34,766
+35
+0.1% +$85 ﹤0.01% 3982
2018
Q3
$197K Buy
34,731
+3,036
+10% +$17.2K ﹤0.01% 3927
2018
Q2
$247K Buy
31,695
+6,307
+25% +$49.2K ﹤0.01% 3871
2018
Q1
$180K Buy
25,388
+11,889
+88% +$84.3K ﹤0.01% 3941
2017
Q4
$133K Buy
13,499
+661
+5% +$6.51K ﹤0.01% 4010
2017
Q3
$110K Sell
12,838
-32
-0.2% -$274 ﹤0.01% 3995
2017
Q2
$135K Buy
+12,870
New +$135K ﹤0.01% 3972